LATEST NEWS

Molecular Testing for Thyroid Nodules What is Molecular Testing? Molecular testing is an advanced laboratory technique that analyses the genetic material (DNA and RNA) within thyroid nodule cells obtained during a fine needle aspiration (FNA) biopsy. By looking for specific gene mutations, gene fusions, and other genetic alterations, molecular testing helps determine whether a thyroid nodule is likely to be benign (non-cancerous) or malignant (cancerous). It is particularly h

John has recently returned from a conference in Egypt organised by Professor Hisham Mehanna who was Head and neck fellow in Auckland in 2003-2004 and is now Professor of Head and Neck Surgery at the University of Birmingham , Honorary Consultant Head and Neck and Thyroid Surgeon at University Hospitals Birmingham NHS Foundation Trust , and Director of the Institute of Head and Neck Studies and Education (InHANSE). Originally Egyptian and brought up in the UAE, Hisham, who Joh

Dr John Chaplin to Chair Session at the 10th Multidisciplinary Update on Thyroid and Parathyroid Diseases in Noosa in November Leading New Zealand head and neck surgeon Dr John Chaplin  will attend and chair a session at the 10th Multidisciplinary Update on Thyroid and Parathyroid Diseases , to be held in Noosa, Queensland, Australia , from 6–9 November 2025 . This prestigious biennial meeting brings together international experts in endocrine surgery, otolaryngology, endocri

The ATA Guidelines for the management of thyroid nodules and differentiated thyroid cancer were first published in 1996 and then updated in 2006, 2009 and 2015. In the latest 2025 update thyroid nodules are separated out and the manuscript focuses on differentiated thyroid cancer. There are significant changes in recommendations that have been developed from evidence gathered in the past 10+ years and I have provided a summary of the major differences between the 2015 and